AMANDA KUBILUS: Open Payments
NPI 1497264618 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 31 payments from 10 companies in 2025. Trend: 2023 $1,014 · 2024 $341 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $259 |
| Exact Sciences Corporation | 3 | $84 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Astellas Pharma US Inc | 2 | $31 |
| Amgen Inc. | 1 | $19 |
| MILLICENT US INC | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $16 |
| COLOPLAST CORP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: UBRELVY, The Cologuard Plus Collection Kit, BOTOX, FANAPT, Veozah, QULIPTA, EVENITY, INTRAROSA.
Industry payments across PA — which companies pay providers there.
